MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Cash Flow PerformanceCompressed
Percentile Rank20
Studio
Year-over-Year Change

Free cash flow yield

Latest
-36.62%
↓ 87% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive growthCompressed
Average
-19.61%
Historical baseline
PeriodValueYoY Change
2024-36.62%+15.0%
2023-43.07%-98.0%
2022-21.75%-148.4%
2021-8.76%-312.3%
2020-2.12%+60.1%
2019-5.32%-